62nd ASH Annual Meeting and Exposition

You may search for particular presentations by typing key words, an author's name, or the title in the box below. You may specify the type of search, i.e. whether you want to see pages that contain any or all of the words you specify. The Boolean search option requires one of the keywords and, or, and not, as well as parentheses.

The search filters will allow you to restrict your search by date, session type, or abstract category and are all optional. Hold down the Ctrl key while selecting to choose more than one option in each list, or hold down the Shift key to select a range.

Search:

Restrict search results to:

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
denotes an abstract that is clinically relevant

No Restriction
Wednesday, December 2, 2020
Thursday, December 3, 2020
Friday, December 4, 2020
Saturday, December 5, 2020
Sunday, December 6, 2020
Monday, December 7, 2020
Tuesday, December 8, 2020
Wednesday, December 9, 2020
Thursday, December 10, 2020

No Restriction
101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
102. Regulation of Iron Metabolism
112. Thalassemia and Globin Gene Regulation
113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science
113. Hemoglobinopathies, Excluding Thalassemia—New Genetic Approaches to Sickle Cell Disease
114. Hemoglobinopathies, Excluding Thalassemia—Clinical
201. Granulocytes, Monocytes, and Macrophages
203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections
301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry
311. Disorders of Platelet Number or Function
321. Blood Coagulation and Fibrinolytic Factors
322. Disorders of Coagulation or Fibrinolysis
331. Pathophysiology of Thrombosis
332. Anticoagulation and Antithrombotic Therapy
401. Basic Science and Clinical Practice in Blood Transfusion
501. Hematopoietic Stem and Progenitor Biology
502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation
503. Clonal Hematopoiesis: Aging and Inflammation
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells
508. Bone Marrow Failure
602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
603. Oncogenes and Tumor Suppressors
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases
605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases
612. Acute Lymphoblastic Leukemia: Clinical Studies
613. Acute Myeloid Leukemia: Clinical Studies
614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis
618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis
621. Lymphoma—Genetic/Epigenetic Biology
622. Lymphoma Biology—Non-Genetic Studies
623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies
624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies
625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents
626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials
627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies
631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
632. Chronic Myeloid Leukemia: Therapy
634. Myeloproliferative Syndromes: Clinical
635. Myeloproliferative Syndromes: Basic Science
636. Myelodysplastic Syndromes—Basic and Translational Studies
637. Myelodysplastic Syndromes—Clinical Studies
641. CLL: Biology and Pathophysiology, excluding Therapy
642. CLL: Therapy, excluding Transplantation
651. Myeloma: Biology and Pathophysiology, excluding Therapy
652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
653. Myeloma/Amyloidosis: Therapy, excluding Transplantation
701. Experimental Transplantation: Basic Biology, Pre-Clinical Models
703. Adoptive Immunotherapy: Mechanisms and New Approaches
704. Immunotherapies
711. Cell Collection and Processing
721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
731. Clinical Autologous Transplantation: Results
732. Clinical Allogeneic Transplantation: Results
801. Gene Editing, Therapy and Transfer
802. Chemical Biology and Experimental Therapeutics
803. Emerging Diagnostic Tools and Techniques
901. Health Services Research—Non-Malignant Conditions
902. Health Services Research—Malignant Conditions (Lymphoid Disease)
903. Health Services Research—Malignant Conditions (Myeloid Disease)
904. Outcomes Research—Non-Malignant Conditions
905. Outcomes Research—Malignant Conditions (Lymphoid Disease)
906. Outcomes Research—Malignant Conditions (Myeloid Disease)
A Map for the Changing Landscape of CLL
ASH Choosing Wisely® Campaign: 2020 ASH Choosing Wisely Champions
ASH Talks
ASH-a-Palooza
Acute Myeloid Leukemia - So Many Treatment Options; How Do You Decide?
Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time?
Anxiety Provoking Hematology Consults, Second Edition
Appropriate Use of Imaging in Patients with Lymphoma
Beyond the Marrow: Major Non-Hematologic Complications of Inherited Bone Marrow Failure Syndromes
Blood Buddy Forum
Blood Drops
Caring for Patients with Acute Leukemia in Community Hospitals: Who, What, and When to Refer?
Cellular Breakups: Transfusion and Hyperhemolysis in Sickle Cell Disease
Challenges in Cell Therapy: Relapse and Toxicities
Challenging Situations for Patients with Aggressive Lymphomas
Checkpoint Blockade: Defining A New Treatment Paradigm in Hodgkin Lymphoma and Allogeneic Transplantation
Chronic Transfusion Support: Challenging Cases
Diagnostic and Prognostic Models in VTE Management: Ready for Primetime?
Emicizumab’s Impact on the Landscape of Hemophilia A Treatment: Two Artists Debate the View
Extrinsic Regulation of Hematopoietic Stem Cell Emergence and Homeostasis
Friend or Foe: The Microbiome, Antibiotics and Death After Transplant
Genetic Testing for Heritable Hematologic Disorders 101
Getting the Most from Minimal Residual Disease
Gut Microbiome and the Endothelium
Handling Challenging Questions in the Management of CML
Hematopoietic Aging: Mechanisms and Consequences
How to Manage Common Challenging Situations in Patients with Multiple Myeloma
Immunotherapy in Multiple Myeloma
Improving Symptom Control for Children with Hematological Malignancies
Indolent Lymphomas: Answers to Smoldering Questions
Infection Risk, Immunization Recommendations, and Antimicrobial Prophylaxis Needs when Treating Non-Malignant Hematologic Disorders - Wash Your Hands and What Else?
Junior Faculty Career Development Education Session
Location, Location, Location
Managing Toxicities of Targeted Therapies in CLL
Mechanisms and Modifiers of Bleeding
Medical Educators' Symposium
Molecular Basis of Platelet/Megakaryocyte Dysfunction: Novel Approaches
Monoclonal Gammopathies of Determined Significance
Myelodysplastic Syndromes: What We Have and What We Want
Myeloproliferative Disorders: Too Many Cells, Too Few Therapies - How Do We Choose?
Novel Blood Therapeutics
Out of Balance: Anemias Due to Disordered Iron Homeostasis
Pediatric Hematological Malignancies: CARs for Kids
Platelet Transfusions for Hematology / Oncology Patients: Taking a More Granular Look
Precision Medicine Approaches to Leukemia Predisposition in Bone Marrow Failure
Presentations
Press Briefing
RNA in Normal and Malignant Hematopoiesis
Scientific Workshop on Epidemiology: Disparities in Hematologic Diseases: Risk, Outcomes and Care
Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Scientific Workshop on Hematology & Aging: Exploring Biomarkers, CHIP, CAR-T and Clotting
Scientific Workshop on Hematology and Pregnancy
Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma
Scientific Workshop on Infectious Disease and Coagulation
Scientific Workshop on Interplay Between Coagulation and Malignancy
Scientific Workshop on Myeloid Development
Scientific Workshop on Translational Molecular Diagnostics in Hematology
Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies
Scientific Workshop on What ‘Omics Are Telling Us About Molecular Mechanisms in Sickle Cell Disease
Selected Hemostasis and Thrombosis Topics in Women
Single Cell Analysis of Hematopoietic Development and Clonal Complexity of Malignant Hematopoiesis
Special Joint Education-Scientific Symposium: Hormones and Hematology
Special Symposium on the Basic Science of Hemostasis and Thrombosis
The Brain and Pain in Sickle Cell Disease: Understanding the Role of Sensory, Cognition and Neuropathic Pathways in the SCD Chronic Pain Experience
The Emerging Role of Targeted Therapies and Cell Therapy in Transplant
The Immune System in Multiple Myeloma
Trainee Didactic Sessions
Transfusion and Anemia in Global Health
Understanding How to Manipulate the Immune System in Immunotherapy for Lymphoma
Updates on the Role of Non-Anticoagulant Interventions in Venous Thromboembolism
Vascular Anomalies 101: Case-Based Discussion on the Diagnosis, Treatment and Lifelong Care of These Patients
Well-Regulated vs Malfunctioning Mechanisms of Iron Metabolism
What Hematologists Need to Know About Giving and Stopping Aspirin
What the Children Can Teach Us: Congenital Immunodeficiencies Shed Light on Immunity, Hematopoiesis, and Cancer
Yin and Yang of Autoimmunity and Immunodeficiencies in Hematology
Zen

No Restriction
Coronaviruses
Coronaviruses - SARS-CoV-2/COVID-19
Diseases
Diseases - Anemias
Diseases - Anemias - aplasia
Diseases - Anemias - aplastic anemia
Diseases - Anemias - Diamond Blackfan Anemia
Diseases - Anemias - Fanconi Anemia
Diseases - Anemias - iron deficiency
Diseases - Anemias - PNH
Diseases - Bleeding and Clotting
Diseases - Bleeding and Clotting - Bleeding Disorders
Diseases - Bleeding and Clotting - Drug-induced thrombocytopenia
Diseases - Bleeding and Clotting - Hemophilia
Diseases - Bleeding and Clotting - Hemostasis
Diseases - Bleeding and Clotting - HIT
Diseases - Bleeding and Clotting - ITP
Diseases - Bleeding and Clotting - Thrombosis
Diseases - Bleeding and Clotting - Platelet Disorders
Diseases - Bleeding and Clotting - Protein Disorders
Diseases - Bleeding and Clotting - Thromboembolism
Diseases - Bleeding and Clotting - Thrombocytopenias
Diseases - Bleeding and Clotting - Thrombotic Disorders
Diseases - Bleeding and Clotting - TTP
Diseases - Bleeding and Clotting - Vascular Wall
Diseases - Bleeding and Clotting - VTE
Diseases - Bleeding and Clotting - VWD
Diseases - Bone Marrow Failure
Diseases - Genetic Disorders
Diseases - Hemoglobinopathies
Diseases - Hemoglobinopathies - sickle cell disease
Diseases - Hemoglobinopathies - sickle cell trait
Diseases - Hemoglobinopathies - thalassemia
Diseases - Immune Disorders
Diseases - Immune Disorders - autoimmune disorders
Diseases - Immune Disorders - Eosinophilia
Diseases - Immune Disorders - GVHD
Diseases - Immune Disorders - GVD
Diseases - Immune Disorders - immunodeficiency
Diseases - Immune Disorders - Leucopenia
Diseases - Immune Disorders - Lymphocytopenia
Diseases - Immune Disorders - Neutropenia
Diseases - Immune Disorders - Neutrophilia
Diseases - Immune Disorders - Proliferative disorders
Diseases - Immune Disorders - white blood cell disorders
Diseases - Immune Disorders - Mastocytosis
Diseases - Infectious Diseases
Diseases - Infectious Diseases - viral
Diseases - Infectious Diseases - bacterial
Diseases - Lymphoid Malignancies
Diseases - Lymphoid Malignancies - Leukemia
Diseases - Lymphoid Malignancies - Leukemia - ALL
Diseases - Lymphoid Malignancies - Leukemia - CLL
Diseases - Lymphoid Malignancies - Leukemia - LGLL
Diseases - Lymphoid Malignancies - Lymphoma (any)
Diseases - Lymphoid Malignancies - Hodgkin Lymphoma
Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma
Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Follicular Lymphoma
Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Marginal Zone Lymphoma
Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Mantle Cell Lymphoma
Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - CNS Lymphoma
Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - DLBCL
Diseases - Lymphoid Malignancies - B-Cell Lymphoma
Diseases - Lymphoid Malignancies - T-Cell Lymphoma
Diseases - Lymphoid Malignancies - Plasma Cell Disorders
Diseases - Lymphoid Malignancies - Plasma Cell Disorders - multiple myeloma
Diseases - Lymphoid Malignancies - Plasma Cell Disorders - smoldering myeloma
Diseases - Myeloid Malignancies
Diseases - Myeloid Malignancies - AML
Diseases - Myeloid Malignancies - CML
Diseases - Myeloid Malignancies - CMML
Diseases - Myeloid Malignancies - MDS
Diseases - Myeloid Malignancies - MPN
Diseases - Myeloid Malignancies - Polycythemia vera
Diseases - Myeloid Malignancies - thrombocythemia
Therapies
Therapies - Biological
Therapies - Biological - antibodies
Therapies - Biological - bone marrow
Therapies - Biological - CAR-Ts
Therapies - Biological - checkpoint inhibitors
Therapies - Biological - enzyme inhibitors
Therapies - Biological - gene therapy
Therapies - Biological - immunotherapy
Therapies - Biological - infusion
Therapies - Biological - NK cells
Therapies - Biological - transfusion
Therapies - Biological - transplantation
Therapies - Biological - TKI
Therapies - Biological - stem cells
Therapies - Biological - vaccines
Therapies - Non-Biological
Therapies - Non-Biological - anticoagulant drugs
Therapies - Non-Biological - chemical interactions
Therapies - Non-Biological - chemotherapy
Therapies - Non-Biological - coagulant drugs
Therapies - Non-Biological - devices
Therapies - Non-Biological - opioids
Therapies - Non-Biological - palliative care
Therapies - Non-Biological - pharmacology
Therapies - Combinations
Therapies - Combinations - therapy sequence
Therapies - Combinations - drug-drug interaction
Adverse Events
Adverse Events - CRS
Adverse Events - neurotoxicity
Biological Processes
Biological Processes - apoptosis
Biological Processes - cell division
Biological Processes - cell regulation
Biological Processes - cellular interactions
Biological Processes - DNA damage
Biological Processes - DNA repair
Biological Processes - epigenetics
Biological Processes - erythropoiesis
Biological Processes - genomics
Biological Processes - hematopoiesis
Biological Processes - immune mechanism
Biological Processes - inflammation
Biological Processes - integrative -omics
Biological Processes - iron metabolism
Biological Processes - iron transport
Biological Processes - metabolomics
Biological Processes - microenvironment
Biological Processes - molecular interactions
Biological Processes - multi-systemic interactions
Biological Processes - pathogenesis
Biological Processes - pathways
Biological Processes - proteomics
Biological Processes - senescence
Biological Processes - signal transduction
Technology and Procedures
Technology and Procedures - apheresis
Technology and Procedures - bioengineering
Technology and Procedures - biopsy
Technology and Procedures - blood banking
Technology and Procedures - blood product storage
Technology and Procedures - cell expansion
Technology and Procedures - cytogenetics
Technology and Procedures - gene editing
Technology and Procedures - genetic profiling
Technology and Procedures - imaging
Technology and Procedures - flow cytometry
Technology and Procedures - mass cytometry
Technology and Procedures - molecular testing
Technology and Procedures - newborn screening
Technology and Procedures - NGS
Technology and Procedures - radiation
Technology and Procedures - RNA sequencing
Technology and Procedures - serologic tests
Technology and Procedures - WGS
Cell Lineage
Cell Lineage - HSCs
Cell Lineage - iPSCs
Cell Lineage - platelets
Cell Lineage - red blood cells
Cell Lineage - white blood cells
Cell Lineage - immune cells
Study Population
Study Population - Adult
Study Population - Animal models
Study Population - Elderly
Study Population - Pediatric
Study Population - Pregnancy
Study Population - Young Adult
Study Population - Xenograft models
Clinically relevant
Quality Improvement
Quality Improvement - survivorship

62nd ASH Annual Meeting and Exposition

Restrict search results to:

Meeting Program